Showing results (31-40 of 320) with videos related to
Sort By:
Pageof 32
Current Opinion in Gastroenterology|June 3, 2005
Medical treatment of inflammatory bowel diseasesGert Van Assche, Séverine Vermeire, Paul RutgeertsCore Evidence|January 12, 2011
Infliximab: the evidence for its place in therapy in ulcerative colitisGert Van Assche, Séverine Vermeire, Paul RutgeertsNature Reviews. Gastroenterology & Hepatology|February 6, 2010
The potential for disease modification in Crohn's diseaseG Van Assche, Séverine Vermeire, Paul RutgeertsCurrent Opinion in Gastroenterology|June 9, 2006
Safety issues with biological therapies for inflammatory bowel diseaseGert Van Assche, Séverine Vermeire, Paul RutgeertsGastroenterology Clinics of North America|November 30, 2006
Focus on mechanisms of inflammation in inflammatory bowel disease sites of inhibition: current and future therapiesGert Van Assche, Séverine Vermeire, Paul RutgeertsCurrent Opinion in Gastroenterology|May 7, 2009
Immunosuppression in inflammatory bowel disease: traditional, biological or both?Gert Van Assche, Séverine Vermeire, Paul RutgeertsBiologics : Targets & Therapy|August 27, 2009
Adalimumab in Crohn's diseaseGert Van Assche, Séverine Vermeire, Paul RutgeertsCurrent Opinion in Gastroenterology|November 25, 2010
Inflammatory bowel disease and colitis: new concepts from the bench and the clinicSéverine Vermeire, Gert Van Assche, Paul RutgeertsWorld Journal of Gastroenterology|June 15, 2006
Pharmacogenetics in inflammatory bowel diseaseMarie Pierik, Paul Rutgeerts, Robert Vlietinck, et al.Journal of the American College of Nutrition|January 19, 2007
Influence of long-term administration of lactulose and Saccharomyces boulardii on the colonic generation of phenolic compounds in healthy human subjectsVicky De Preter, Tamara Coopmans, Paul Rutgeerts, et al.Pageof 32